Skip to main content

Using PML nuclear body biology to identify potential AML treatment targets

Project description

Understanding PML nuclear bodies disruption in the context of AML treatment

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution
€ 184 707,84
Address
Rue De Tolbiac 101
75654 Paris
France

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Non-EU contribution
€ 0,00